Long-term oncological results of breast conservative treatment with oncoplastic surgery

被引：201

作者：

Rietjens, M. ^{[1
]}

Urban, C. A. ^{[1
]}

Rey, P. C. ^{[1
]}

Mazzarol, G. ^{[3
]}

Maisonneuve, P. ^{[4
]}

Garusi, C. ^{[1
]}

Intra, M. ^{[2
]}

Yamaguchi, S. ^{[1
]}

Kaur, N. ^{[1
]}

De Lorenzi, F. ^{[1
]}

Matthes, A. G. Z. ^{[1
]}

Zurrida, S. ^{[2
]}

Petit, J. Y. ^{[1
]}

机构：

[1] European Inst Oncol, Dept Plast & Reconstruct Surg, Milan, Italy

[2] European Inst Oncol, Dept Breast Surg, Milan, Italy

[3] European Inst Oncol, Dept Pathol, Milan, Italy

[4] European Inst Oncol, Dept Epidemiol & Stat, Milan, Italy

来源：

BREAST | 2007年 / 16卷 / 04期

关键词：

breast cancer; plastic surgery; breast conserving therapy; oncoplastic breast surgery;

D O I：

10.1016/j.breast.2007.01.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Oncoplastic surgery combining breast conservative treatment (BCT) and plastic surgery techniques may allow more extensive breast resections and improve aesthetic outcomes, but no long-term oncological results have been published. Long-term oncologic results of 148 consecutive BCT with concomitant bilateral plastic surgery have been analysed and were compared to historical data of BCT trials. Median follow-up was 74 months. Complete excision was obtained in 135 patients (91%); focally involved margins in 8 (5%); and close (< 2 mm) margins in 5 (3%). Five patients developed ipsilateral recurrence (3%), 19 (13%) developed distant metastasis and 11 patients died (7.53%). Patients with tumours larger than 2 cm were at greater risk of local recurrences and distant metastasis. Long-term oncologic results of BCT with oncoplastic surgery are comparable with the results of BCT randomized trials. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：387 / 395

页数：9

共 24 条

[11] Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study [J].

Page, DL ;

Schuyler, PA ;

Dupont, WD ;

Jensen, RA ;

Plummer, WD ;

Simpson, JF .

LANCET, 2003, 361 (9352) :125-129

[12] Contralateral mastoplasty for breast reconstruction: A good opportunity for glandular exploration and occult carcinomas diagnosis [J].

Petit, JY ;

Rietjens, M ;

Contesso, G ;

Bertin, F ;

Gilles, R .

ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (06) :511-515

[13]

Pitanguy I, 1967, Br J Plast Surg, V20, P78, DOI 10.1016/S0007-1226(67)80009-2

[14]

RIETJENS M, 1997, EUR J PLAST SURG, V20, P245

[15] Perspectives and risks of breast-conservation therapy for breast cancer [J].

Roukos, DH ;

Kappas, AA ;

Agnantis, NJ .

ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (07) :718-721

[16] Revision of the American Joint Committee on Cancer staging system for breast cancer [J].

Singletary, SE ;

Allred, C ;

Ashley, P ;

Bassett, LW ;

Berry, D ;

Bland, KI ;

Borgen, PI ;

Clark, CG ;

Edge, SB ;

Hayes, DF ;

Hughes, LL ;

Hutter, RVP ;

Morrow, M ;

Page, DL ;

Recht, A ;

Theriault, RL ;

Thor, A ;

Weaver, DL ;

Wieand, HS ;

Greene, FL .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3628-3636

[17] Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy [J].

Singletary, SE .

AMERICAN JOURNAL OF SURGERY, 2002, 184 (05) :383-393

[18]

SMITT MC, 1995, CANCER-AM CANCER SOC, V76, P259, DOI 10.1002/1097-0142(19950715)76:2<259::AID-CNCR2820760216>3.0.CO

[19]

2-2

[20] Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer [J].

Spear, SL ;

Pelletiere, CV ;

Wolfe, AJ ;

Tsangaris, TN ;

Pennanen, MF .

PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 111 (03) :1102-1109

← 1 2 3 →